Literature DB >> 9825824

Sulfation-dependent down-regulation of interferon-gamma-induced major histocompatibility complex class I and II and intercellular adhesion molecule-1 expression on tubular and endothelial cells by glycosaminoglycans.

B A Yard1, C P Lorentz, D Herr, F J van der Woude.   

Abstract

BACKGROUND: Previously, it has been demonstrated that heparin inhibits major histocompatibility complex (MHC) class II and intercellular adhesion molecule-1 (ICAM-1) expression on interferon-gamma (IFN-gamma)-stimulated human umbilical vein endothelial cells (HUVECs). Inasmuch as proximal tubular epithelial cells (PTECs) are prime targets in acute renal allograft rejection, we investigated whether there is a difference in the ability of heparin to influence MHC and ICAM-1 expression on PTECs as compared to HUVECs. We also studied whether the degree of sulfation of heparin is of relevance for the binding to IFN-gamma and inhibition of MHC and ICAM-1 expression after IFN-gamma stimulation.
METHODS: Cultured HUVECs and PTECs were stimulated with IFN-gamma for 72 hr in the presence or absence of various heparinoids. MHC and ICAM-1 expression were thereafter determined by fluorescence-activated cell sorting.
RESULTS: Heparin was able to inhibit the up-regulation of MHC and ICAM-1 in a dose-dependent fashion on both IFN-gamma-stimulated HUVECs and PTECs. In PTEC cultures, higher concentrations of heparin were required for the inhibition of MHC class I. Heparin and supersulfated glycosaminoglycans (GAGs) were able to bind to IFN-gamma, whereas N-desulfated N-acetylated GAGs with a low amount of sulfate were not. Inhibition of cell-bound heparan sulfate proteoglycan sulfation with NaClO3 resulted in an impaired MHC and ICAM-1 expression after IFN-gamma stimulation.
CONCLUSION: We postulate that IFN-gamma binds to cell-bound heparan sulfate proteoglycan in a sulfation-dependent fashion. This binding may facilitate the interaction of IFN-gamma with its receptor. Supersulfated GAGs with low anti-coagulant activity could be used therapeutically to decrease MHC and ICAM-1 expression on organ grafts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9825824     DOI: 10.1097/00007890-199811150-00021

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft Rejection.

Authors:  Hao Chen; Sriram Ambadapadi; Dara Wakefield; Meeyong Bartee; Jordan R Yaron; Liqiang Zhang; Stephanie A Archer-Hartmann; Parastoo Azadi; Michelle Burgin; Chad Borges; Donghang Zheng; Kevin Ergle; Vishnu Muppala; Sufi Morshed; Kenneth Rand; William Clapp; Amanda Proudfoot; Alexandra Lucas
Journal:  Sci Rep       Date:  2018-09-07       Impact factor: 4.379

2.  Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro.

Authors:  Dmitry Samsonov; Christopher Geehan; Craig B Woda; David M Briscoe
Journal:  Transplant Res       Date:  2012-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.